The heat wave is here - is your skin ready? This week on the podcast, Heather and Matthew are joined by Dr. Charles Darragh and Dr. Marshall Shuler of Carolina Dermatology, one of the largest dermatology practices in upstate South Carolina. They share tips for keeping your skin safe in the summer and how their practice is integrating AI to enhance patient care. The doctors also discuss their bold decision to go against national trends in physician employment by leaving a large health system to launch an independent practice, and how that benefits their patients. Tune in now!

Heather and Matthew welcome Chuck Melendi, a seasoned healthcare consultant and former executive with decades of experience in pharmaceuticals, biotech, and medical devices. Chuck joins us to examine the complexities of the federal 340B pricing program, which provides discounted outpatient drugs to eligible health care providers. From ongoing litigation and proposed legislative reform to the role of PBMs, Chuck shares insights into why a seemingly good faith regulation is one of the most debated topics in health care policy. Tune in for a thoughtful discussion on how healthcare leaders and government can preserve the mission of 340B while addressing its challenges.

This week, Heather and Matthew are joined by their colleague Bryan Baysinger, Maynard Nexsen attorney and leader of the firm’s Intellectual Property practice group. We dive into the evolving challenges life sciences companies face in protecting intellectual property in a time when artificial intelligence is reshaping research and innovation. From securing patents and trade secrets to navigating international competition, Bryan offers practical guidance for companies looking to strengthen their IP portfolios. Tune in for insights on the intersection of IP, AI, and the future of the life sciences industry!

In this episode, Heather and Matthew welcome Dr. Leonardo Ferreira, Assistant Professor at the Medical University of South Carolina and cofounder of Torpedo Bio. Leo shares how his team at Torpedo Bio is working to develop safe and effective cellular immunotherapy for solid tumors. We have an exciting conversation on the promise of CAR-T therapy, the challenges life sciences startups face, and how federal research funding impacts innovation. Tune in to hear how Torpedo Bio is pushing the boundaries of cancer treatment!